Financials
Income statement
| Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 502.8M | 228.9M | 258.8M | 415.3M |
| Cost of revenue | 1.3B | 198.0M | 452.0M | 363.6M |
| Gross profit | -798.3M | 30.8M | -193.2M | 51.6M |
| Operating expense | ||||
| Research & development | 495.8M | 413.6M | 467.5M | 507.8M |
| Selling general and admin | 107.9M | 129.9M | 127.5M | 234.7M |
| Other operating expenses | -14.5M | 11.4M | 5.9M | 10.3M |
| Operating income | -1.6B | -793.8M | -1.0B | -976.4M |
| Non operating interest income | ||||
| Income | 2.3M | 6.7M | 11.0M | 11.3M |
| Expense | 36.0M | 25.3M | 22.1M | 24.2M |
| Other income expense | — | — | — | — |
| Pretax income | -1.5B | -573.2M | -1.0B | -860.4M |
| Tax provision | — | — | — | — |
| Net income | -1.5B | -573.2M | -1.0B | -860.4M |
| Basic EPS | — | -24 | -44 | -37 |
| Diluted EPS | — | -24 | -44 | -37 |
| Basic average shares | — | 23.9M | 23.5M | 23.3M |
| Diluted average shares | — | 23.9M | 23.5M | 23.3M |
| EBITDA | -1.2B | -310.1M | -782.9M | -640.5M |
| Net income from continuing op. | -1.5B | -573.2M | -1.0B | -860.4M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |